← All stocks

GENELUX Corp

GNLX Net selling

CIK 0001231457 #4219 in the set updated 17 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$146.67K

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$146.67K

3 of 3 sales

Net

−$146.67K

−$146.67K against sales at will

By person

12 insiders · 3 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Zindrick Thomas

President and CEO

—

$91.90K (1)

−$91.90K

1,226,427

2.71%

$3.38M

+2,093%

Cappello Joseph

Chief Technical Officer

—

$28.11K (1)

−$28.11K

318,480

0.7039%

$876.81K

+1,420%

Yu Yong

Chief Scientific Officer

—

$26.66K (1)

−$26.66K

258,688

0.5717%

$712.19K

+1,408%

Thomas John

Director

—

501,193

1.11%

$1.38M

−0.9%

Pulisic Matthew

Chief Financial Officer

—

278,906

0.6164%

$767.86K

—

Groen Eric

General Counsel

—

233,957

0.5171%

$644.11K

—

Mirabelli Mary

Director

—

102,693

0.2270%

$282.72K

+97.5%

Tyree James L

Director

—

96,483

0.2132%

$265.63K

+95.9%

Smither John W

Director

—

91,403

0.2020%

$251.64K

+73.4%

Zak Lourie S.

Chief Financial Officer

—

82,452

0.1822%

$227.00K

+92.2%

Smalling Ralph

Head of Regulatory

—

67,611

0.1494%

$186.14K

+259.0%

Ryder Sean

General Counsel

—

47,621

0.1053%

$131.11K

+145.6%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 3

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 3

Transactions with no price 0

Shares from compensation/vesting 0

History held since 30 Jan 2023